
|Articles|May 10, 2004
Botulinum toxin shows promising results in refractory OAB
Known primarily for smoothing facial wrinkles, botulinumtoxin A (Botox) is gaining acceptance as a treatment option for refractoryoveractive and neurogenic bladder. The latest evidence comes from the Universityof Pittsburgh School of Medicine, where a 110-patient review of the off-labeluse of botulinum toxin for those indications produced promising resultsin terms of both safety and efficacy.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD
5

